Approvals/TGA/XILECAND HCT 32/12.5 candesartan cilexetil and hydrochlorothiazide 32/12.5 mg tablet blister pack

Approved

STANDARD

XILECAND HCT 32/12.5 candesartan cilexetil and hydrochlorothiazide 32/12.5 mg tablet blister pack

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: f4bffce1be47eda3
Product Name: XILECAND HCT 32/12.5 candesartan cilexetil and hydrochlorothiazide 32/12.5 mg tablet blister pack
Artg Id: 297014
Artg Name: XILECAND HCT 32/12.5 candesartan cilexetil and hydrochlorothiazide 32/12.5 mg tablet blister pack
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2019-06-11
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

f4bffce1be47eda3

Type

Standard